Low Blood Glucose Index Associated with Cardiovascular Events in Diabetic kidney disease Patients

Blood glucose monitoring was vitally important in diabetic kidney disease (DKD) patients for preventing complications and improving survival rates. The associations between glycemic variability and blood biochemical indicators were underestimated in patients with DKD undergoing hemodialysis. Therefore, we primarily aimed to investigate the glycemic variability and 1-year risk of cardiovascular disease events in diabetic hemodialysis patients. And we secondarily aimed to explore the association between glycemic variability and blood biochemical indicators.

In total, 27 patients were included in the final analysis. Continuous glucose monitoring (CGM) was used to evaluate glucose variability for 14 days. Patients were divided into two groups by the cutoff level of time in range (TIR; >70% or ≤70%). The three-point major adverse cardiovascular event (3P MACE) was recorded within 1 year.

Results: After 1 year of follow-up, 4 patients in the high-TIR group and 3 patients in the low-TIR group had 3p MACE. Higher low blood glucose index (LBGI) level in diabetic hemodialysis patients increased the risk of 3p MACE outcomes (HR = 2.37, p = 0.018). And the level of albumin was positively associated with Low Blood Glucose Index (β = 0.51, p = 0.036). The plasma levels of albumin, glycosylated hemoglobin, and hemoglobin were positively associated with other CGM parameters.

Low Blood Glucose Index during 14 days was positively associated with the risk of cardiovascular events in diabetic hemodialysis patients.

Reference:

He R, Xuan Y, Zhu L, Pang S, Qin L, Tian J, Yuan J. Low Blood Glucose Index Associated with Cardiovascular Events in Diabetic Hemodialysis Patients. Blood Purif. 2023 Aug 22:1-11. doi: 10.1159/000531964. Epub ahead of print. PMID: 37607516.

Keywords:

Low, Blood, Glucose, Index, Associated, Cardiovascular, Events, Diabetic, Hemodialysis, Patients,Blood Purification, Cardiovascular disease; Continuous glucose monitoring; Diabetic kidney disease; Glycemic variability; Hemodialysis, He R, Xuan Y, Zhu L, Pang S, Qin L, Tian J, Yuan J.